Expression Pattern and Molecular Mechanism of Oxidative Stress-Related Genes in Myocardial Ischemia–Reperfusion Injury

(1) Background: The molecular mechanism of oxidative stress-related genes (OSRGs) in myocardial ischemia–reperfusion injury (MIRI) has not been fully elucidated. (2) Methods: Differential expression analysis, enrichment analysis, and PPI analysis were performed on the MIRI-related datasets GSE160516 and GSE61592 to find key pathways and hub genes. OSRGs were obtained from the Molecular Signatures Database (MSigDB). The expression pattern and time changes of them were studied on the basis of their raw expression data. Corresponding online databases were used to predict miRNAs, transcription factors (TFs), and therapeutic drugs targeting common differentially expressed OSRGs. These identified OSRGs were further verified in the external dataset GSE4105 and H9C2 cell hypoxia–reoxygenation (HR) model. (3) Results: A total of 134 DEGs of MIRI were identified which were enriched in the pathways of “immune response”, “inflammatory response”, “neutrophil chemotaxis”, “phagosome”, and “platelet activation”. Six hub genes and 12 common differentially expressed OSRGs were identified. A total of 168 miRNAs, 41 TFs, and 21 therapeutic drugs were predicted targeting these OSRGs. Lastly, the expression trends of Aif1, Apoe, Arg1, Col1a1, Gpx7, and Hmox1 were confirmed in the external dataset and HR model. (4) Conclusions: Aif1, Apoe, Arg1, Col1a1, Gpx7, and Hmox1 may be involved in the oxidative stress mechanism of MIRI, and the intervention of these genes may be a potential therapeutic strategy.

[1]  N. Zhou,et al.  Identification of a novel oxidative stress-related prognostic model in lung adenocarcinoma , 2022, Frontiers in Pharmacology.

[2]  M. Hacker,et al.  Metformin confers longitudinal cardiac protection by preserving mitochondrial homeostasis following myocardial ischemia/reperfusion injury , 2022, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  Fen Liu,et al.  Targeted activation of ERK1/2 reduces ischemia and reperfusion injury in hyperglycemic myocardium by improving mitochondrial function , 2022, Annals of translational medicine.

[4]  Q. Shu,et al.  Targeting Ferroptosis as a Promising Therapeutic Strategy for Ischemia-Reperfusion Injury , 2022, Antioxidants.

[5]  Hao Jianbing,et al.  The Effect of Allograft Inflammatory Factor-1 on Inflammation, Oxidative Stress, and Autophagy via miR-34a/ATG4B Pathway in Diabetic Kidney Disease , 2022, Oxidative medicine and cellular longevity.

[6]  Lijun Sun,et al.  Biodegradable Redox-Responsive AIEgen-Based-Covalent Organic Framework Nanocarriers for Long-Term Treatment of Myocardial Ischemia/Reperfusion Injury. , 2022, Small.

[7]  C. Duan,et al.  Oxidative-Damaged Mitochondria Activate GABARAPL1-Induced NLRP3 Inflammasomes in an Autophagic-Exosome Manner after Acute Myocardial Ischemia , 2022, Oxidative medicine and cellular longevity.

[8]  G. Karimi,et al.  Induction of JAK2/STAT3 pathway contributes to protective effects of different therapeutics against myocardial ischemia/reperfusion. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[9]  Yue Zhang,et al.  Analysis of the potential ferroptosis mechanism and multitemporal expression change of central ferroptosis-related genes in cardiac ischemia–reperfusion injury , 2022, Frontiers in Physiology.

[10]  Yundai Chen,et al.  Potential of immune-related genes as promising biomarkers for premature coronary heart disease through high throughput sequencing and integrated bioinformatics analysis , 2022, Frontiers in Cardiovascular Medicine.

[11]  Yangang Xing,et al.  Targeting MCOLN1/TRPML1 channels to protect against ischemia-reperfusion injury by restoring the inhibited autophagic flux in cardiomyocytes , 2022, Autophagy.

[12]  Peng Zeng,et al.  Analysis of susceptibility genes and myocardial infarction risk correlation of ischemic cardiomyopathy based on bioinformatics , 2022, Journal of thoracic disease.

[13]  J. Jozwiak,et al.  Oxidative Stress Markers in Hypertrophic Cardiomyopathy , 2021, Medicina.

[14]  Maoqing Ye,et al.  Association of Pericardiac Adipose Tissue With Coronary Artery Disease , 2021, Frontiers in Endocrinology.

[15]  Bing Han,et al.  PHLDA3 inhibition protects against myocardial ischemia/reperfusion injury by alleviating oxidative stress and inflammatory response via the Akt/Nrf2 axis , 2021, Environmental toxicology.

[16]  Hongli Li,et al.  Sp1 Targeted PARP1 Inhibition Protects Cardiomyocytes From Myocardial Ischemia–Reperfusion Injury via Downregulation of Autophagy , 2021, Frontiers in Cell and Developmental Biology.

[17]  R. Rodrigo,et al.  Targeting Ferroptosis against Ischemia/Reperfusion Cardiac Injury , 2021, Antioxidants.

[18]  Ying Zhang,et al.  Dexmedetomidine reversed hypoxia/reoxygenation injury-induced oxidative stress and endoplasmic reticulum stress-dependent apoptosis of cardiomyocytes via SIRT1/CHOP signaling pathway , 2021, Molecular and Cellular Biochemistry.

[19]  Hui-Ching Cheng,et al.  Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK , 2021, Cell & bioscience.

[20]  Jing Wang,et al.  Puerarin protects against myocardial ischemia/reperfusion injury by inhibiting inflammation and the NLRP3 inflammasome: The role of the SIRT1/NF-κB pathway. , 2020, International immunopharmacology.

[21]  Wan-gang Guo,et al.  Bakuchiol Alleviates Hyperglycemia-Induced Diabetic Cardiomyopathy by Reducing Myocardial Oxidative Stress via Activating the SIRT1/Nrf2 Signaling Pathway , 2020, Oxidative medicine and cellular longevity.

[22]  Zhiqiang Liu,et al.  Protective Effect of Pravastatin on Myocardial Ischemia Reperfusion Injury by Regulation of the miR-93/Nrf2/ARE Signal Pathway , 2020, Drug design, development and therapy.

[23]  Qinghang Liu,et al.  NFκB promotes oxidative stress-induced necrosis and ischemia/reperfusion injury by inhibiting Nrf2-ARE pathway. , 2020, Free radical biology & medicine.

[24]  G. Sethi,et al.  The multifaceted role of reactive oxygen species in tumorigenesis , 2020, Cellular and Molecular Life Sciences.

[25]  Xiaowei Wang,et al.  miRDB: an online database for prediction of functional microRNA targets , 2019, Nucleic Acids Res..

[26]  Hui Li,et al.  A novel circRNA-miRNA-mRNA network identifies circ-YOD1 as a biomarker for coronary artery disease , 2019, Scientific Reports.

[27]  J. Ge,et al.  Excessive Neutrophil Extracellular Trap Formation Aggravates Acute Myocardial Infarction Injury in Apolipoprotein E Deficiency Mice via the ROS-Dependent Pathway , 2019, Oxidative medicine and cellular longevity.

[28]  C. Normann,et al.  Platelet Serotonin Aggravates Myocardial Ischemia/Reperfusion Injury via Neutrophil Degranulation , 2019, Circulation.

[29]  Q. Fu,et al.  The Lncrna, H19 Mediates the Protective Effect of Hypoxia Postconditioning Against Hypoxia-Reoxygenation Injury to Senescent Cardiomyocytes by Targeting MicroRNA-29b-3p. , 2019, Shock.

[30]  Y. Huo,et al.  Arginase 1 promotes retinal neurovascular protection from ischemia through suppression of macrophage inflammatory responses , 2018, Cell Death & Disease.

[31]  P. Hruz,et al.  Metabolic and Cardiac Adaptation to Chronic Pharmacologic Blockade of Facilitative Glucose Transport in Murine Dilated Cardiomyopathy and Myocardial Ischemia , 2018, Scientific Reports.

[32]  Hyojin Kim,et al.  TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions , 2017, Nucleic Acids Res..

[33]  V. Fuster,et al.  Effect of Ischemia Duration and Protective Interventions on the Temporal Dynamics of Tissue Composition After Myocardial Infarction , 2017, Circulation research.

[34]  D. Saint,et al.  The role of Toll‐like receptor 4 (TLR4) in cardiac ischaemic‐reperfusion injury, cardioprotection and preconditioning , 2016, Clinical and experimental pharmacology & physiology.

[35]  Mark J. Miller,et al.  DAP12 Expression in Lung Macrophages Mediates Ischemia/Reperfusion Injury by Promoting Neutrophil Extravasation , 2015, The Journal of Immunology.

[36]  S. Akira,et al.  Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis. , 2013, Cardiovascular research.

[37]  Katherine A. Bakeev,et al.  Bioengineering Silicon Quantum Dot Theranostics using a Network Analysis of Metabolomic and Proteomic Data in Cardiac Ischemia , 2012, Theranostics.

[38]  W. El-Rifai,et al.  Glutathione peroxidase 7 protects against oxidative DNA damage in oesophageal cells , 2011, Gut.

[39]  Liyong Pu,et al.  Allograft inflammatory factor-1 is up-regulated in warm and cold ischemia-reperfusion injury in rat liver and may be inhibited by FK506. , 2011, The Journal of surgical research.

[40]  X. Zhou,et al.  Cardiac allograft rejection correlates with increased expressions of Toll-like receptors 2 and 4 and allograft inflammatory factor 1. , 2010, Transplantation proceedings.

[41]  M. Soares,et al.  Mechanisms of cell protection by heme oxygenase-1. , 2010, Annual review of pharmacology and toxicology.

[42]  Yu-yu Yao,et al.  HO-1 gene overexpression enhances the beneficial effects of superparamagnetic iron oxide labeled bone marrow stromal cells transplantation in swine hearts underwent ischemia/reperfusion: an MRI study , 2010, Basic Research in Cardiology.

[43]  K. Chatila,et al.  CD44 Is Critically Involved in Infarct Healing by Regulating the Inflammatory and Fibrotic Response1 , 2008, The Journal of Immunology.

[44]  P. Moore,et al.  Cardioprotective effects of nitric oxide-aspirin in myocardial ischemia-reperfused rats. , 2007, American journal of physiology. Heart and circulatory physiology.

[45]  N. Frangogiannis Chemokines in ischemia and reperfusion , 2007, Thrombosis and Haemostasis.

[46]  A. Ho,et al.  Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. , 2005, Blood.

[47]  M. Layne,et al.  Absence of heme oxygenase-1 exacerbates myocardial ischemia/reperfusion injury in diabetic mice. , 2005, Diabetes.

[48]  J. Genest,et al.  Molecular interactions between apoE and ABCA1: impact on apoE lipidation. , 2004, Journal of lipid research.

[49]  L. Becker Myocardial Reperfusion Injury , 2004, Journal of Thrombosis and Thrombolysis.